Overexpression of snail accelerates adriamycin induction of multidrug resistance in breast cancer cells

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 10, 2011, Pages 2575-2580

  Li, Wentong ^a   Liu, Chuanliang ^a   Tang, Yong ^a   Li, Hongli ^b   Zhou, Fenghua ^a   Lv, Shijun ^a  

^a WEIFANG PEOPLE'S HOSPITAL   (China)

^b WEIFANG MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; EMT cells; Gp; Multidrug resistance; P; Snail

Indexed keywords

EID: 84863242623     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Azinun N, Bhurgri Y, Raza F, Kayani N (2008). Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer. Asian Pac J Cancer Prev, 9, 553-6.
2. Barr S, Thomson S, Buck E, et al (2008). Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions. Clin Exp Metastasis, 25, 685-93.
3. Batlle E, Sancho E, Franci C, et al (2000). The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol. 2, 84-9.
4. Batlle E, Sancho E, Francí C, et al (2000). The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol, 2, 84-9.
5. Pitman RS, et al (1997). The human KB multidrug-resistant cell line KB-C1 is hypersensitive to inhibitors of glycosylation. Cancer Lett, 115, 221-7.
6. Brouckaert O, Pintens S, Van Belle V, et al (2009). Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors. Breast Cancer Res Treat, 115, 349-58.
7. Buck E, Eyzaguirre A, Barr S, et al (2007). Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition. Mol Cancer Ther, 6, 532-41.
8. Cano A, Perez-Moreno MA, Rodrigo I, et al (2000). The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol, 2, 76-83.
9. Carver EA, Jiang R, Lan Y, et al (2001). The mouse snail gene encodes a key regulator of the epithelial-mesenchymal transition. Mol Cell Biol, 21, 8184-8.
10. Carver EA, Jiang R, Lan Y, et al (2001). The mouse snail gene encodes a key regulator of the epithelial-mesenchymal transition. Mol Cell Biol, 21, 8184-8188.
11. Cho HJ, Baek KE, Saika S, Jeong MJ, Yoo J (2007). Snail is required for transforming growth factor-beta-induced epithelial-mesenchymal transition by activating PI3 kinase/Akt signal pathway. Biochem Biophys Res Commun, 353, 337-43.
12. Frederick BA, Helfrich BA, Coldren CD, et al (2007). Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinoma. Mol Cancer Ther, 6, 1683-91.
13. Fuchs IB, Lichtenegger W, Buehler H, et al (2002). The prognostic significance of epithelial-mesenchymal transition in breast cancer. Anticancer Res, 22, 3415-9.
14. Fuchs IB, Lichtenegger W, Buehler H, et al (2008). Signaling networks assembled by oncogenic EGFR and c-Met. Proc Natl Acad Sci USA, 105, 692-7.
15. Grandis JR, Sok JC (2004). Signaling through the epidermal growth factor receptor during the development of malignancy. Pharmacol Ther, 102, 37-46.
16. Gupta GP, Massagué J (2006). Cancer metastasis: building a framework. Cell, 127, 679-95.
17. Haddad Y, Choi W, McConkey DJ (2009). Delta-crystallin enhancer binding factor 1 controls the epithelial to mesenchymal transition phenotype and resistance to the epidermal growth factor receptor inhibitor erlotinib in human head and neck squamous cell carcinoma lines. Clin Cancer Res, 15, 532-42.
18. Hirohashi S, Kanai Y (2003). Cell adhesion system and human cancer morphogenesis. Cancer Sci, 94, 575-81.
19. Hosono S, Kajiyama H, Terauchi M, et al (2007). Expression of Twist increases the risk for recurrence and for poor survival in epithelial ovarian carcinoma patients. Br J Cancer, 96, 314-20.
20. Kajiyama H, Shibata K, Terauchi M, et al (2007). Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells. Int J Onco, 31, 277-83.
21. Kalluri R, Weinberg RA (2009). The basics of epithelial-mesenchymal transition. J Clin Invest, 119, 1420-8.
22. Kokkinos MI, Wafai R, Wong MK, et al (2007). Vimentin and epithelial-mesenchymal transition in human breast cancer-observations in vitro and in vivo. Cells Tissues Organs, 185, 191-203.
23. Lee JM, Dedhar S, Kalluri R, Thompson EW (2006). The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol, 172, 973-81.
24. Leroy P, Mostov KE (2007). Slug is required for cell survival during partial epithelial-mesenchymal transition of HGF induced tubulogenesis. Mol Biol Cell, 18, 1943-52.
25. Li QQ, Xu JD, Wang WJ, et al (2009). Twist1-mediated adriamycin-induced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells. Clin Cancer Res, 15, 2657-65.
26. Mani SA, Guo W, Liao MJ, et al (2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell, 133, 704-15.
27. Marin F, Peinado H, Cubillo E, et al (2004). Snail and E47 repressors of E-cadherin induce distinct invasive and angiogenic properties in vivo. J Cell Sci, 117, 2827-39.
28. Moody SE, Perez D, Pan TC, et al (2005). The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell, 8, 197-209.
29. Moustakas A, Heldin CH (2007). Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci, 98, 1512-20.
30. Peinado H, Ballestar E, Esteller M, et al (2004). Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol Cell Biol, 24, 306-19.
31. Sario D, Rodriguez-Pinilla SM, Hardisson D, et al (2008). Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res, 68, 989-97.
32. Shrader M, Pino MS, Brown G, et al (2007). Molecular correlates of gefitinib responsiveness in human bladder cancer cells. Mol Cancer Ther, 6, 277-85.
33. Spaderna S, Schmal hofer O, Hlubek F, et al (2007). Epithelial-mesenchymal and mesenchymal-epithelial transitions during cancer progression. Verh Dtsch Ges Pathol, 91, 21-8.
34. Zhang B, Groffen J, Heisterkamp N (2007). Increased resistance to a farnesyltransferase inhibitor by N-cadherin expression in Bcr/Abl-P190 lymphoblastic leukemia cells. Leukemia, 21, 1189-97.
35. Zhang Z, Xie D, Li X, et al (2007). Significance of TWIST expression and its association with E-cadherin in bladder cancer. Hum Pathol, 38, 598-606.